Request Appointment
6560 Fannin StSte 802Houston, TX 77030
Fax+1 713-790-5079
Overview of Dr. Mokhtari
Dr. Sepideh Mokhtari is a neurologist in Houston, TX and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Houston Methodist Hospital. She received her medical degree from Texas AM Health Science Center College of Medicine and has been in practice 11 years. She is one of 39 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 122 doctors at Houston Methodist Hospital who specialize in Neurology. She has more than 20 publications and over 150 citings.
Education & Training
Methodist Hospital (Houston)Residency, Neurology, 2011 - 2014
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2010 - 2011
Texas A&M; Health Science Center College of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2016 - 2027
NY State Medical License 2014 - 2017
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease Start of enrollment: 2020 Dec 10
Publications & Presentations
PubMed
- 1 citationsClinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary
British Journal of Neurosurgery. 2025-04-01 - Molecular Underpinnings of Brain Metastases.Maria A Jacome, Qiong Wu, Jianan Chen, Zaynab Sidi Mohamed, Sepideh Mokhtari
International Journal of Molecular Sciences. 2025-03-05 - Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, Heiko Enderling, Nam D Tran
Neuro-Oncology Advances. 2025-02-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
